Skip to content

The effect of a combination of dietary intervention and functional therapy using ingredient analytical instrument in fatty liver patients: a randomized controlled trial.

The effect of a combination of dietary intervention and functional therapy using ingredient analytical instrument in fatty liver patients: a randomized controlled trial. - Dietary and functional intervention study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029849
Enrollment
26
Registered
2017-11-07
Start date
2014-05-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatty liver diseases Non-alcoholic Fatty Liver Diseases Non-alcoholic steatohepatitis

Interventions

Educational intervention 12 months

Sponsors

National Center for Global Health and Medicine The Research Center for Hepatitis and Immunology Department of Liver Disease
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patient diagnosed as fatty liver 2. Patient aged over 20 years old and under 75 3. PS 0 - 1 (ECOG) 4. Patient can intake orally 5. Informed Consent has been obtained in writing form.by himself / herself about examination participation

Exclusion criteria

Exclusion criteria: 1. Patient who has been infected with hepatitis virus 2. Patient has a clear drinking history (Alcohol amount: over 20 g / day) 3. patient who has difficulties in doing exercise, such as any joint pain, kidney dysfunction or heart disease 4. Patient who has poorly controlled diabetes 5. Patient who was judged as inappropriate for this research by physichans.

Design outcomes

Primary

MeasureTime frame
Changes from baseline of skeletal muscle mass; body fat mass; basal metabolism rate; and visceral fat area, at one, two, three, six, nine, and 12 months after the start of the intervention.

Secondary

MeasureTime frame
Motor function test (6 minutes walking distance, grip strength,Knee extension muscle strength), blood biochemical test (AST,ALT, GTP, TG,HDL-cho LDL-cho, BS, insulin, iron, ferritin, FFA Hyaluronic acid, type IV collagen 7S, etc.), abdominal supersonic Wave test (liver hardness, rate of change of hepatic fat mass).

Countries

Japan

Contacts

Public ContactMasashi FURUTA

National Center for Global Health and Medicine The Research Center for Hepatitis and Immunology

masashi.furuta@med.toho-u.ac.jp047-372-3501

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026